Science Daily·3 min read·medium
Millions may be getting the wrong cholesterol test
✦AI Summary
New research suggests that measuring apolipoprotein B (apoB) is more effective than standard LDL cholesterol tests for predicting heart attack and stroke risk. The study indicates that this approach is both more accurate and cost-effective for healthcare systems.
Millions of Americans have a blood test every year to measure LDL, often called "bad" cholesterol. But new research from Northwestern Medicine suggests that another test may do a better job of identifying who needs more aggressive treatment to reduce the risk of heart attacks and strokes.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in